Smiling woman sitting in front of green wall at AlkermesSmiling woman sitting in front of green wall at AlkermesBlue Triangle graphic

News and Events

Sharing Stories of
Patients, Employees
and Communities

Featured News

March 23, 2023

Journal of Clinical Psychiatry Publishes Data from Alkermes' ENLIGHTEN-Early Study of LYBALVI® (olanzapine and samidorphan) in Young Adults Early in...

Read more

March 15, 2023

Alkermes to Participate in the Stifel 2023 CNS Days

Read more

February 16, 2023

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2022 and Provides Financial Expectations for 2023

Read more

See all press releases

Our Commitment to Responsibility

Corporate responsibility has always played a central role in our business and has proven even more critical during the past year as we faced some of the most pressing public health and societal issues of our time – a dynamic global pandemic, systemic racism in the U.S. and around the world, and a worsening climate change crisis. Guided by our purpose and values, we took actions to respond to these critical issues, while sharpening our focus on scientific and business excellence in our efforts to help people living with complex and difficult-to-treat diseases. Our most recent Corporate Responsibility Report expounds on these efforts.

Corporate Responsibility reports   

Our Stories

Each endeavor at Alkermes starts with collaboration and our shared commitment to make a difference for patients and our communitiesThese stories – which highlight our people, science and innovation, and leadership perspectives – showcase just a subset of what makes us proud to be part of Alkermes. Visit our full gallery of stories by clicking on the link below.

Markus Haeberlein, Ph.D.

Showcasing Alkermes’ Commitment to the Sleep Community

Hear from Markus Haeberlein, Ph.D. where he discusses our commitment to researching potential treatment options for people living with sleep disorders.

Read the post

Embracing Diversity at Alkermes

This Women’s History Month, we celebrate the accomplishments of the many women making a difference at Alkermes. Meet the co-leads of Mosaic, our ERG dedicated to multicultural diversity.

Learn about Mosaic

Mosaic Employee Resource Group Logo

Portrait of Craig Hopkinson in cafeteria

Seeking to Fill Cancer Treatment Gaps

Hear from Dr. Craig Hopkinson in this PharmaVoice article where he discusses our commitment to developing novel potential therapies for people living with difficult-to-treat cancers.

Read the article

Media Resources

Company Description

Alkermes is focused on developing innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated, global biopharmaceutical company, with U.S. locations in Massachusetts and Ohio, and locations in Dublin and Athlone, Ireland, we apply our scientific expertise and proprietary technologies to develop products designed to make a meaningful difference in the way people manage their diseases. Beyond our scientific pursuits, we also work to help support and enhance the systems through which these complex diseases are treated. We are committed to patient engagement, disease education and supporting policies that enable access to approved treatment options.

Media Inquiries

Email our media team

Company Logos


Company Photo


Corporate Fact Sheet


Follow us on our social channels   

blue triangle graphic

Statements and Positions

The idea that a corporation can play a profoundly positive role in society is central to our vision. It is our obligation to voice our beliefs about issues that impact the patients we serve, the communities in which we live and work and society at large.

Company Statement on the Invasion of Ukraine

Read our statement

Systemic Racism and Violence

Read our statement